Clinical effects of methylphenidate hydrochloride extended-release tablets on improvement of intelligence and
1Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, China.
Insights
Methylphenidate hydrochloride extended-release tablets significantly improved intelligence, behavior, and quality of life in children with attention deficit hyperactivity disorder (ADHD). Treatment also increased key neurotransmitter levels in these children.
Area of Science:
- Neuroscience
- Pediatric Psychiatry
- Pharmacology
Background:
- Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
- Effective treatments are crucial for managing ADHD symptoms and improving long-term outcomes.
- Methylphenidate is a widely prescribed stimulant medication for ADHD.
Purpose of the Study:
- To investigate the effects of methylphenidate hydrochloride extended-release tablets on intelligence and behavior in children with ADHD.
- To assess the impact of this treatment on neurotransmitter levels.
- To evaluate changes in self-awareness and quality of life.
Main Methods:
- A randomized controlled trial involving 120 children diagnosed with ADHD.
- Participants were divided into a treatment group (methylphenidate hydrochloride extended-release tablets) and a placebo control group.
- Assessments of intelligence, behavior, self-awareness, quality of life, and neurotransmitter levels were conducted over 12 weeks.
Main Results:
- The methylphenidate group showed significant improvements in intelligence, self-awareness, and quality of life compared to the placebo group.
- Behavioral scores and clinical symptoms were reduced in the treatment group.
- Levels of 5-hydroxytryptamine, norepinephrine, and dopamine were elevated in the methylphenidate group post-treatment.
Conclusions:
- Methylphenidate hydrochloride extended-release tablets are effective in improving cognitive function, attention, and behavior in children with ADHD.
- The medication positively impacts self-awareness and quality of life.
- Treatment with methylphenidate hydrochloride leads to favorable changes in monoamine neurotransmitter levels.
Abstract:
This study aimed to investigate the impacts of methylphenidate hydrochloride extended-release tablets on intelligence and behavior in children with attention deficit hyperactivity disorder. One hundred and twenty children with attention deficit hyperactivity disorder admitted to Nanjing First Hospital, Nanjing Medical University, Nanjing, China from January 2023 to January 2025 were included and randomly divided into a control group and a study group. The study group adopted methylphenidate hydrochloride extended release tablets. The control group adopted placebo. Compared with the control group, the study group had an increase in intelligence level scores, self-awareness scores and quality of life scores as well as a decrease in behavior scores and clinical symptoms scores following 12 weeks of treatment. Compared with the control group, 5-hydroxytryptamine, norepinephrine and dopamine levels in the study group were higher after 12 weeks of treatment. However, the above indicators showed no differences in the control group between before and after treatment. We conclude that methylphenidate hydrochloride extended-release tablets improve the intelligence level, attention and behavior problems, promote self-awareness and quality of life, and improve the levels of monoamine neurotransmitters in children with attention deficit hyperactivity disorder..
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Environmental Influences on Intelligence
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Information Processing Approach
Biological Influences on Intelligence
